ALL vs HALO · P/E 4.9, rev $18.60B vs P/E 15, rev $857.7M
The Allstate Corporation (ALL) versus Halozyme Therapeutics Inc (HALO) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Not investment advice. Open the ALL and HALO stock pages for the full models.
Not investment advice.